Signals, Powered By EquityPandit
Aarti Drugs has received approval from the board to buyback shares at a price of Rs.875 per share, through tender offer.
The company in a statement said, “The board approved a buyback of up to 0.27 million equity shares representing up to 1.5% of total equity of the company at a price of Rs.875 per equity share for an aggregate amount of up to Rs.241 million, on a proportionate basis through the tender offer.”
Furthermore, the company has fixed January 19,2018 as the record date for buying back shares.
